Main Article Content
Abstract
Infections caused by the dengue virus (DENV) exhibit a wide range of clinical manifestations, from asymptomatic cases to severe, and sometimes life-threatening, conditions. Therefore, identifying effective antivirals and anti-inflammatory agents is a promising strategy to reduce the impact of these infections. Indonesia, with its rich biodiversity, particularly in medicinal plants, offers potential sources for such treatments. Most research on DENV antivirals in Indonesia has been conducted in vitro and has predominantly focused on DENV serotype 2 (DENV-2). However, in vivo research on medicinal plants, as well as studies on their anti-inflammatory properties, remains limited in Indonesia.Extracts that have been investigated in both in vivo and in vitro settings are limited to Cassia alata and Curcuma longa. Plants possessing antiviral properties originate from diverse botanical families, with leaves being the most utilized plant component. Flavonoids are found in most medicinal plants that have antiviral properties. Indonesia is known to have other natural compounds, including quercetin, isobutyl gallate, curcumin, and 6-gingerol, which have antiviral properties. Curcumin and 6-gingerol are the only natural compounds that have been subjected to testing against all four serotypes of dengue. This article provides a comprehensive review of medicinal plants in Indonesia, focusing specifically on their therapeutic potential against the dengue virus.
Keywords
Article Details
Copyright (c) 2024 Aisya Alma Asmiranti Kartika, Beti Ernawati Dewi, Tjahjani Mirawati Sudiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.